These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19197231)

  • 21. Involvement of multiple efflux transporters in hepatic disposition of fexofenadine.
    Matsushima S; Maeda K; Hayashi H; Debori Y; Schinkel AH; Schuetz JD; Kusuhara H; Sugiyama Y
    Mol Pharmacol; 2008 May; 73(5):1474-83. PubMed ID: 18245269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence of early burn-induced effects on liver function as reflected by the plasma disappearance rate of indocyanine green: a prospective descriptive cohort study.
    Steinvall I; Fredrikson M; Bak Z; Sjoberg F
    Burns; 2012 Mar; 38(2):214-24. PubMed ID: 22040928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatic expression of ABC transporters G5 and G8 does not correlate with biliary cholesterol secretion in liver transplant patients.
    Geuken E; Visser DS; Leuvenink HG; de Jong KP; Peeters PM; Slooff MJ; Kuipers F; Porte RJ
    Hepatology; 2005 Nov; 42(5):1166-74. PubMed ID: 16250035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of genetic backgrounds on hyperbilirubinemia in radixin-deficient mice due to different expression levels of Mrp3.
    Fukumoto K; Kikuchi S; Itoh N; Tamura A; Hata M; Yamagishi H; Tsukita S; Tsukita S
    Biochim Biophys Acta; 2007 Mar; 1772(3):298-306. PubMed ID: 17204408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nine cases with marked retention of indocyanine green test and normal sulfobromophthalein test without abnormal liver histology: constitutional indocyanine green excretory defect.
    Namihisa T; Nambu M; Kobayashi N; Kuroda H
    Hepatogastroenterology; 1981 Feb; 28(1):6-12. PubMed ID: 7216141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma disappearance of indocyanine green: a marker for excretory liver function?
    Stehr A; Ploner F; Traeger K; Theisen M; Zuelke C; Radermacher P; Matejovic M
    Intensive Care Med; 2005 Dec; 31(12):1719-22. PubMed ID: 16231068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the role of multidrug resistance-associated protein (Mrp) 3 and Mrp4 in hepatic basolateral excretion of sulfate and glucuronide metabolites of acetaminophen, 4-methylumbelliferone, and harmol in Abcc3-/- and Abcc4-/- mice.
    Zamek-Gliszczynski MJ; Nezasa K; Tian X; Bridges AS; Lee K; Belinsky MG; Kruh GD; Brouwer KL
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1485-91. PubMed ID: 16988054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liquiritigenin, a flavonoid aglycone from licorice, has a choleretic effect and the ability to induce hepatic transporters and phase-II enzymes.
    Kim YW; Kang HE; Lee MG; Hwang SJ; Kim SC; Lee CH; Kim SG
    Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G372-81. PubMed ID: 19074639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of hepatic drug transporter activity and expression by organochlorine pesticides.
    Bucher S; Le Vee M; Jouan E; Fardel O
    J Biochem Mol Toxicol; 2014 Mar; 28(3):119-28. PubMed ID: 24464585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor.
    Yamada A; Maeda K; Kamiyama E; Sugiyama D; Kondo T; Shiroyanagi Y; Nakazawa H; Okano T; Adachi M; Schuetz JD; Adachi Y; Hu Z; Kusuhara H; Sugiyama Y
    Drug Metab Dispos; 2007 Dec; 35(12):2166-76. PubMed ID: 17823233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of liver blood flow and function on hepatic indocyanine green clearance measured directly in a cirrhotic animal model.
    Jiao LR; El-Desoky AA; Seifalian AM; Habib N; Davidson BR
    Br J Surg; 2000 May; 87(5):568-74. PubMed ID: 10792311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases.
    Zollner G; Fickert P; Zenz R; Fuchsbichler A; Stumptner C; Kenner L; Ferenci P; Stauber RE; Krejs GJ; Denk H; Zatloukal K; Trauner M
    Hepatology; 2001 Mar; 33(3):633-46. PubMed ID: 11230744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of caloric restriction on the kinetics of indocyanine green in patients with liver diseases and in the rat.
    Ohkubo H; Musha H; Okuda K
    Am J Dig Dis; 1978 Nov; 23(11):1017-24. PubMed ID: 717358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatic transport of indocyanine green in dogs chronically intoxicated with dimethylnitrosamine.
    Kawasaki S; Umekita N; Beppu T; Wada T; Sugiyama Y; Iga T; Hanano M
    Toxicol Appl Pharmacol; 1984 Sep; 75(2):309-17. PubMed ID: 6474462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relation between indocyanine green (ICG) plasma disappearance rate and ICG blood clearance in critically ill patients.
    Sakka SG; van Hout N
    Intensive Care Med; 2006 May; 32(5):766-9. PubMed ID: 16544120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High expression of MDR1, MRP1, and MRP3 in the hepatic progenitor cell compartment and hepatocytes in severe human liver disease.
    Ros JE; Libbrecht L; Geuken M; Jansen PL; Roskams TA
    J Pathol; 2003 Aug; 200(5):553-60. PubMed ID: 12898590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatocyte Concentrations of Indocyanine Green Reflect Transfer Rates Across Membrane Transporters.
    Cusin F; Fernandes Azevedo L; Bonnaventure P; Desmeules J; Daali Y; Pastor CM
    Basic Clin Pharmacol Toxicol; 2017 Feb; 120(2):171-178. PubMed ID: 27623731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Species differences in biliary clearance and possible relevance of hepatic uptake and efflux transporters involvement.
    Grime K; Paine SW
    Drug Metab Dispos; 2013 Feb; 41(2):372-8. PubMed ID: 23139379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kinetic analysis of hepatobiliary transport of organic anions in Eisai hyperbilirubinemic mutant rats.
    Sathirakul K; Suzuki H; Yasuda K; Hanano M; Tagaya O; Horie T; Sugiyama Y
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1301-12. PubMed ID: 8510010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transporter studies with the 3-O-sulfate conjugate of 17alpha-ethinylestradiol: assessment of human liver drug transporters.
    Han YH; Busler D; Hong Y; Tian Y; Chen C; Rodrigues AD
    Drug Metab Dispos; 2010 Jul; 38(7):1072-82. PubMed ID: 20360302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.